Product Detail

Name: Eptifibatide   Feature:  Integrin is a new type of peptide platelet glycoprotein Ⅱ b/Ⅲ a receptor antagonist, which inhibits platelet aggregation and thrombosis through the last common way of inhibiting platelet aggregation. Compared with the monoclonal antibody abciximab, etibalide has stronger binding to GP Ⅱ b/Ⅲ a, more directivity and specificity due to the existence of a single conservative amino acid substitution-lysine instead of arginine. Therefore, it should play a good role in the interventional treatment of acute coronary syndrome.   Composition: Assay: 99% Appearance: White powder CAS No. 188627-80-7 Packing: 25kg Shelf Life: 2 years Storage: Store in cool and dry area Certification:ISO.